$ALNY
ALNYLAM PHARMACEUTICALS, INC.

2016 Q3 Form 10-Q Financial Statement

#000119312516671945 Filed on August 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $13.70M $8.700M $8.700M
YoY Change 117.46% 0.0% 19.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $22.40M $18.00M $14.60M
YoY Change 40.0% 23.29% 26.96%
% of Gross Profit
Research & Development $97.94M $83.17M $67.01M
YoY Change 42.73% 24.12% 50.0%
% of Gross Profit
Depreciation & Amortization $3.500M $4.000M $5.000M
YoY Change -33.96% -20.0% 72.41%
% of Gross Profit
Operating Expenses $120.3M $101.2M $81.63M
YoY Change 42.14% 23.93% 56.08%
Operating Profit -$106.7M -$92.45M -$72.94M
YoY Change 36.19% 26.74% 62.08%
Interest Expense $2.200M $2.100M $1.600M
YoY Change 37.5% 31.25% 128.57%
% of Operating Profit
Other Income/Expense, Net $2.605M $2.321M $1.592M
YoY Change 69.38% 45.79% 158.44%
Pretax Income -$104.1M -$90.13M -$71.35M
YoY Change 35.56% 26.32% 60.74%
Income Tax $0.00 $400.0K
% Of Pretax Income
Net Earnings -$104.1M -$90.13M -$71.78M
YoY Change 35.52% 25.56% 62.87%
Net Earnings / Revenue -759.64% -1035.97% -825.09%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.215M -$1.054M -$850.7K
COMMON SHARES
Basic Shares Outstanding 85.72M shares 85.56M shares 84.28M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $699.5M $843.1M $940.0M
YoY Change -28.45% -10.31% 55.29%
Cash & Equivalents $168.5M $271.1M $151.3M
Short-Term Investments $531.0M $572.0M $788.7M
Other Short-Term Assets $19.30M $22.20M $15.10M
YoY Change 10.29% 47.02% 46.6%
Inventory
Prepaid Expenses
Receivables $15.10M $9.500M $9.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $747.6M $888.1M $1.029B
YoY Change -28.24% -13.71% 54.73%
LONG-TERM ASSETS
Property, Plant & Equipment $74.22M $55.39M $25.17M
YoY Change 182.03% 120.09% 48.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $339.6M $287.2M $456.8M
YoY Change -5.3% -37.13% 30.29%
Other Assets $1.561M $1.471M $19.70M
YoY Change -83.39% -92.53%
Total Long-Term Assets $565.3M $494.1M $501.6M
YoY Change 43.36% -1.5% 36.48%
TOTAL ASSETS
Total Short-Term Assets $747.6M $888.1M $1.029B
Total Long-Term Assets $565.3M $494.1M $501.6M
Total Assets $1.313B $1.382B $1.531B
YoY Change -8.58% -9.71% 48.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.14M $12.82M $15.72M
YoY Change 62.11% -18.4% 154.78%
Accrued Expenses $36.21M $37.55M $17.76M
YoY Change 96.33% 111.46% 12.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $81.76M $70.58M $66.60M
YoY Change 43.16% 5.97% 23.91%
LONG-TERM LIABILITIES
Long-Term Debt $150.0M $150.0M $0.00
YoY Change
Other Long-Term Liabilities $1.991M $1.777M $55.60M
YoY Change -96.53% -96.8% 5460.0%
Total Long-Term Liabilities $1.991M $1.777M $55.60M
YoY Change -96.53% -96.8% 5460.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.76M $70.58M $66.60M
Total Long-Term Liabilities $1.991M $1.777M $55.60M
Total Liabilities $297.9M $283.7M $122.2M
YoY Change 160.12% 132.21% 35.16%
SHAREHOLDERS EQUITY
Retained Earnings -$1.544B -$1.440B -$1.079B
YoY Change 33.56% 33.42% 21.09%
Common Stock $2.587B $2.567B $2.469B
YoY Change 4.1% 3.95% 36.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.015B $1.098B $1.409B
YoY Change
Total Liabilities & Shareholders Equity $1.313B $1.382B $1.531B
YoY Change -8.58% -9.71% 48.24%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$104.1M -$90.13M -$71.78M
YoY Change 35.52% 25.56% 62.87%
Depreciation, Depletion And Amortization $3.500M $4.000M $5.000M
YoY Change -33.96% -20.0% 72.41%
Cash From Operating Activities -$75.60M -$70.20M -$55.40M
YoY Change 38.97% 26.71% 18.88%
INVESTING ACTIVITIES
Capital Expenditures -$20.30M -$12.60M -$1.300M
YoY Change 212.31% 869.23% -27.78%
Acquisitions
YoY Change
Other Investing Activities -$11.10M -$31.80M -$105.7M
YoY Change -120.11% -69.91% -53.33%
Cash From Investing Activities -$31.40M -$44.30M -$107.0M
YoY Change -164.48% -58.6% -53.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.400M 154.3M 7.100M
YoY Change 22.22% 2073.24% 39.22%
NET CHANGE
Cash From Operating Activities -75.60M -70.20M -55.40M
Cash From Investing Activities -31.40M -44.30M -107.0M
Cash From Financing Activities 4.400M 154.3M 7.100M
Net Change In Cash -102.6M 39.80M -155.3M
YoY Change 4785.71% -125.63% -42.46%
FREE CASH FLOW
Cash From Operating Activities -$75.60M -$70.20M -$55.40M
Capital Expenditures -$20.30M -$12.60M -$1.300M
Free Cash Flow -$55.30M -$57.60M -$54.10M
YoY Change 15.45% 6.47% 20.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
95.00
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85724637 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151262000
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1439806000
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1777000
CY2016Q2 us-gaap Liabilities
Liabilities
283680000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1382162000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
18885000
CY2016Q2 us-gaap Assets
Assets
1382162000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28296000
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
858975000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
572008000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12824000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
571994000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
287229000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1471000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1098482000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22152000
CY2016Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
150000000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
54810000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
856000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2565728000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6518000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1315000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75179000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85090968 shares
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
459000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
70575000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85572768 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85572768 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85090968 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37551000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
211000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
271076000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
286967000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
859223000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Assets
Assets
1386510000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
888068000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1102379000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
251839000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
287229000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55394000
CY2016Q2 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
150000000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
571994000
CY2016Q2 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
13332000
CY2016Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9514000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1246703000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1301000
CY2015Q4 us-gaap Liabilities
Liabilities
121796000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1386510000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15352000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4369000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16787000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1264714000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
52965000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
851000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2506197000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
5431000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
32000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62099000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1162000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28798000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2355000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1105388000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27812000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180895000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1100056000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
848217000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1471000
CY2015Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
51419000
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8298000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16559000
CY2015Q4 alny Litigation Damages Sought
LitigationDamagesSought
8000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3374000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8523000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-81711000
us-gaap Operating Income Loss
OperatingIncomeLoss
-125166000
us-gaap Net Income Loss
NetIncomeLoss
-122560000
dei Document Type
DocumentType
10-Q
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83219000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
us-gaap License And Services Revenue
LicenseAndServicesRevenue
27222000
us-gaap Investment Income Net
InvestmentIncomeNet
2633000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
288000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-30001000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-152561000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
123000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
817670000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2606000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5090000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-30534000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122560000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8711000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1195000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-448264000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
496400000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
20763000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
373068000
us-gaap Share Based Compensation
ShareBasedCompensation
18415000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4138000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
521000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
89018000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27346000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6909000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
606058000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125042000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
76083000
us-gaap Operating Expenses
OperatingExpenses
152388000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10556000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001178670
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.26
dei Entity Registrant Name
EntityRegistrantName
ALNYLAM PHARMACEUTICALS, INC.
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-153828000
dei Trading Symbol
TradingSymbol
ALNY
dei Amendment Flag
AmendmentFlag
false
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85411000 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24380000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
16054000
us-gaap Investment Income Net
InvestmentIncomeNet
3905000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
150000000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26555000
us-gaap Operating Income Loss
OperatingIncomeLoss
-202478000
us-gaap Net Income Loss
NetIncomeLoss
-193103000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-225768000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
163000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
357992000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5470000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9375000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5593000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1216000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-193103000
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
6110000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8612000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3590000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
73605000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6266000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
605977000
us-gaap Share Based Compensation
ShareBasedCompensation
39296000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5378000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
781000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14301000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39087000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1717000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
170404000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
6110000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
179445000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
90181000
us-gaap Operating Expenses
OperatingExpenses
218532000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
150000000
alny Investments Classified As Cash And Cash Equivalent Original Maturities
InvestmentsClassifiedAsCashAndCashEquivalentOriginalMaturities
P90D
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
496400000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
84353000 shares
alny Investment Maturity Period Minimum
InvestmentMaturityPeriodMinimum
P90D
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5447368 shares
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
21100000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2015Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8685000
CY2015Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1619000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-33623000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-72944000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-71783000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105406000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1592000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-71352000
CY2015Q2 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
431000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14622000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67007000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
81629000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85545000 shares
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2016Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8709000
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
2092000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18331000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-92450000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-90129000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-109414000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
229000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2321000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90129000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17987000
CY2016Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
954000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
83172000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
101159000

Files In Submission

Name View Source Status
0001193125-16-671945-index-headers.html Edgar Link pending
0001193125-16-671945-index.html Edgar Link pending
0001193125-16-671945.txt Edgar Link pending
0001193125-16-671945-xbrl.zip Edgar Link pending
alny-20160630.xml Edgar Link completed
alny-20160630.xsd Edgar Link pending
alny-20160630_cal.xml Edgar Link unprocessable
alny-20160630_def.xml Edgar Link unprocessable
alny-20160630_lab.xml Edgar Link unprocessable
alny-20160630_pre.xml Edgar Link unprocessable
d201090d10q.htm Edgar Link pending
d201090dex101.htm Edgar Link pending
d201090dex102.htm Edgar Link pending
d201090dex103.htm Edgar Link pending
d201090dex311.htm Edgar Link pending
d201090dex312.htm Edgar Link pending
d201090dex321.htm Edgar Link pending
d201090dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201090tx19rider.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending